RegReady generates a 15-page regulatory strategy report for your medical device — complete with classification, pathway analysis, testing requirements, and cost estimates. Built for SBIR applications and early-stage planning.
Traditional regulatory consulting is priced for Series A companies, not pre-revenue founders writing their first SBIR grant.
Even when you can afford a consultant, the regulatory assessment takes 3–6 weeks. Your grant deadline is in 10 days.
NIH and NSF reviewers score your regulatory strategy. "We'll figure it out later" costs points you can't afford to lose.
Every report is device-specific — built from FDA databases, not templates. Here's what's inside.
We search four FDA databases in parallel and rank product codes by clearance history, source diversity, and recency. Your report cites the actual regulation number your device falls under.
Named predicate devices from the 510(k) database with clearance dates, applicant companies, and a point-by-point substantial equivalence comparison tailored to your device.
Cost ranges built from fixed reference data, not AI-generated numbers. Every line item traces back to a specific test or submission requirement. Totals always match.
The final section gives you paragraph-ready regulatory strategy text written for SBIR/STTR applications. Drop it directly into your Specific Aims or Commercialization Plan.
Fill out a 10-question intake form: what your device does, how it works, what clinical problem it solves. No regulatory knowledge required.
Your submission is run against live FDA databases — device classification, 510(k) clearances, PMA approvals, and registration data — to find your exact regulatory position.
A 15-page PDF lands in your inbox with classification, pathway, predicates, testing, costs, timeline, and grant-ready language. Ready to use immediately.
You need a credible regulatory strategy section but don't have $15K for a consultant or 6 weeks to wait. Your grant deadline is non-negotiable.
You know your assay or device works. You don't know whether it's a 510(k), De Novo, or PMA — or what the difference means for your timeline and funding.
Your medtech teams need regulatory positioning for demo day and investor conversations. Individual consulting doesn't scale. RegReady does.
No subscriptions, no retainers, no scope creep. Pay once, get your regulatory strategy.
Complete FDA regulatory strategy report for one medical device
You'll fill out a short intake form, then complete payment. Report delivered via email within minutes.